Foley Secures Dismissal in Securities Class Action
June 20, 2025
Media Contacts:
Foley & Lardner LLP represented Vicor Corporation in securing dismissal of a putative securities class action brought by certain Vicor short-sellers in the U.S. District Court for the Northern District of California.
On June 7, 2025, the Court granted Vicor’s motion to dismiss, holding that “there is no plausible averment in the complaint that Defendants’ announcement of expectations omitted material information” and that “Plaintiffs’ complaint is rife with conclusory allegations” that failed “plausibly to aver that Defendants acted with scienter.” The outcome vindicates Vicor’s resolute defense against baseless claims.
The Foley team representing Vicor was led by partners Todd Murray, Phillip Hosp, and Andrew Howell.
People
Related News
July 11, 2025
Deals and Wins
Foley Represents Five Elms Capital in $51M Series C Investment in Spacelift
Foley & Lardner LLP represented Five Elms Capital, a software-focused growth equity firm, in its lead investment in the $51 million Series C funding round of Spacelift, an infrastructure orchestration platform that manages the entire infrastructure lifecycle across multi-cloud and hybrid environments.
July 11, 2025
Deals and Wins
Foley Represents Sorcero in Strategic Acquisition of Axiom Health
Foley & Lardner LLP represented Sorcero in its strategic acquisition of Axiom Health, a medtech DaaS (data-as-a-service) company. This marks a pivotal expansion for Sorcero into the medical device market and expands the company’s product suite to include market and product intelligence.
July 10, 2025
Deals and Wins
Foley Represents Verona Pharma in $10B Acquisition by Merck
Foley & Lardner LLP acted as U.S. intellectual property counsel for UK-based Verona Pharma, a biopharmaceutical company focused on respiratory diseases, in its approximately $10 billion acquisition by Merck & Co. Inc. (Merck).